CSI Laboratories’ cytogenetic laboratory is approved by the Children’s Oncology Group to perform cytogenetic analysis of pediatric oncology specimens.
The approval process for COG requires that laboratories seeking initial or continued approval, exhibit a cytogenetic abnormality detection rate of at least 55% for the samples submitted. During CSI’s recent continued approval process with COG, CSI produced an abnormality detection rate of 100%, while the average abnormality detection rate for participating COG laboratories was 77.1% for Jan-Dec 2015. This means CSI is identifying abnormalities that other labs aren’t finding. This above average abnormality detection rate is just one example of what sets CSI apart from the competition.